Back to Report Store Home

Biosimilars – Regulatory Framework and Pipeline Analysis

  • Published: Jun-2015
  • Report Code: GBI057CBR
  • Report Format: pdf

Description

Table of Contents

Executive Summary

Introduction

Biosimilars Industry Dynamics

Trends

Drivers

Restraints

Biosimilars Regulation: WHO's Guidance

Biosimilars in Europe

Overview

Regulatory Framework

Market Outlook

Biosimilars in the US

Overview

Regulatory Framework

Market Outlook

Biosimilars in India

Overview

Regulatory Framework

Market Outlook

Biosimilars in South Korea

Overview

Regulatory Framework

Market Outlook

Biosimilars in Japan

Overview

Regulatory Framework

Market Outlook

Biosimilars in China

Overview

Regulatory Framework

Market Outlook

Key Market Players

Biosimilars Pipeline Analysis

Overview

By Stage of Development

By Molecule

By Therapy Area

By Indication

By MoA/RoA

Late-Stage Pipeline Biosimilars

Phase II Pipeline Biosimilars

Phase I Pipeline Biosimilars

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$2995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$5990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$8985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards